false
OasisLMS
Catalog
SCCM Resource Library
Biomarker Enhanced Clinical Assessment of Sepsis a ...
Biomarker Enhanced Clinical Assessment of Sepsis and AKI - Organized by bioM‚rieux
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The speaker discusses the problem of acute kidney injury (AKI) in the intensive care unit (ICU). AKI is a major issue that occurs commonly in ICU patients and is more expensive than many other acute medical conditions. The speaker explains that AKI is a result of kidney damage, which leads to a decrease in urine output and an increase in creatinine levels. AKI can occur rapidly, typically within 48 hours of an insult. The speaker emphasizes the importance of early detection and evaluation of AKI to reduce the risk. They discuss the risk factors and outcomes associated with AKI, as well as the economic and health burden it poses. The speaker introduces the nephrocheck test, a urine test that assesses the risk of developing AKI. They explain how the test works and its potential for early identification and management of AKI. The speaker also discusses the use of biomarkers, such as procalcitonin, in identifying and monitoring AKI. They conclude by highlighting the importance of early intervention and management strategies to mitigate AKI and improve patient outcomes.
Asset Subtitle
Sepsis, Renal, 2023
Asset Caption
Type: Non-CE Activities | Biomarker Enhanced Clinical Assessment of Sepsis and AKI - Organized by bioM‚rieux
Meta Tag
Content Type
Presentation
Knowledge Area
Sepsis
Knowledge Area
Renal
Membership Level
Professional
Membership Level
Select
Tag
Sepsis
Tag
Acute Kidney Injury AKI
Year
2023
Keywords
acute kidney injury
intensive care unit
kidney damage
early detection
nephrocheck test
biomarkers
×
Please select your language
1
English